Bisorbicillinol inhibits Lyn tyrosine kinase for allergic response on RBL-2H3 cells

Bioorg Med Chem Lett. 2019 Mar 15;29(6):832-835. doi: 10.1016/j.bmcl.2019.01.019. Epub 2019 Jan 19.

Abstract

Bisorbicillinol, which is isolated from Trichoderma sp. USF2690, is an inhibitor of β-hexosaminidase release and tumor necrosis factor (TNF)-α, and Interleukin (IL)-4 secretion from rat basophilic leukemia (RBL-2H3) cells, with IC50 values of 2.8 μM, 2.9 μM and 2.8 μM respectively. We showed that the inhibitory mechanism of β-hexosaminidase release and TNF-α secretion involved inhibition of Lyn, a tyrosine kinase. The inhibitory activities of bisorbicillinol indicate that this compound is a new candidate anti-allergic agent.

Keywords: Bisorbicillinol; Lyn; RBL-2H3 cells; TNF-α; β-Hexosaminidase.

MeSH terms

  • Animals
  • Anti-Allergic Agents / pharmacology*
  • Bridged-Ring Compounds / pharmacology*
  • Cell Degranulation / drug effects
  • Cell Line, Tumor
  • Mast Cells / drug effects
  • Protein Kinase Inhibitors / pharmacology*
  • Rats
  • Receptors, IgE / metabolism
  • Signal Transduction / drug effects
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • beta-N-Acetylhexosaminidases / antagonists & inhibitors
  • src-Family Kinases / antagonists & inhibitors*

Substances

  • Anti-Allergic Agents
  • Bridged-Ring Compounds
  • Protein Kinase Inhibitors
  • Receptors, IgE
  • Tumor Necrosis Factor-alpha
  • bisorbicillinol
  • lyn protein-tyrosine kinase
  • src-Family Kinases
  • beta-N-Acetylhexosaminidases